'Talented' mother tragically died aged 45 after illness
A "talented" mother from Bolton tragically died aged 45 after suffering with her health.
Jenna Hanley died on March 17 this year at Royal Bolton Hospital.
Ms Hanley had suffered with shortness of breath in the days leading up to her admission to hospital on March 15.
She was diagnosed as suffering with pneumonia, before getting sepsis.
Doctors attempted to treat her but her condition deteriorated and she was put on end-of-life care before her death.
The full inquest into her death was held at Bolton Coroners' Court on June 12.
Area coroner Peter Sigee heard how Ms Hanley had struggled with drug issues since she was 15.
David Kelsey was her "friend and unofficial carer", and had known Ms Hanley for around 10 years.
Mr Kelsey told the court how he would visit her on Mondays, Wednesdays and Fridays to care for her, including taking her to appointments and "assisting with her mobility".
She was heard to have had "poor mobility" due to leg ulcers.
Mr Sigee reflected on how "absolutely scary" the power drugs have over people is.
He added: "Some people can stop and will never go back, but some people can't escape the clutch of drugs, and sadly that might have been the case for Jenna."
Dr Emma Wheatley, a consultant at Royal Bolton Hospital who provided care for Ms Hanley, gave her medical cause of death as septicaemia, caused by pneumococcal pneumonia, with underlying recreational drug use.
Mr Sigee gave a narrative conclusion into her death, saying: "Jenna Hanley's death was caused by a natural disease process, and was contributed to by the effects of long-term recreational drug use."
He added thanks to Mr Kelsey for all of his care of Ms Hanley, as well as the professionals from the mental health team and critical care team for their care.
Speaking to The Bolton News, Mr Kelsey paid tribute to Ms Hanley following the inquest.
He said: "She was a talented lady, she had a lot of talents and she was a really balanced person.
"She was very good with people, she was very good with animals, she could have done a lot more in life, she could have made it, but underperformed because of circumstances."
Mr Kelsey added that her story was a warning to everyone about the dangers of drugs.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Can a Laser Replace MRI Scans? One Bold Experiment Says Yes
In a discovery that could reshape how we view and understand the human brain, researchers have successfully passed a laser beam through an entire human head. While it may sound like science fiction, this quiet milestone could pave the way for faster, cheaper, and noninvasive brain scans. The work comes from a team at the University of Glasgow, who set out to push the limits of functional near-infrared spectroscopy (fNIRS). This technology already offers a portable, low-cost way to monitor brain activity, but until now, it's only been able to peek a few centimeters beneath the skull. For anything deeper, expensive MRI machines have been the standard. That may be about to change. By boosting the power of the laser (within safe limits) and improving the light-collection setup, scientists managed to transmit photons from one side of the skull to the other. It worked on just one out of eight participants—a bald man with fair skin—but it proved something previously thought impossible: a beam of light can travel through the entire human head. The implications are huge. If refined, this technology could close the gap between inexpensive tools like EEG and high-resolution, high-cost MRI scans. In the future, diagnosing strokes, brain injuries, or tumors might not require hospital-grade equipment—just a small, light-based scanner. What made this breakthrough even more compelling was the way the light traveled. Instead of bouncing randomly through the skull, photons followed predictable paths, especially through more transparent areas like cerebrospinal fluid. That opens the door to more targeted imaging, where specific brain regions could be scanned with precision. To validate the experiment, researchers used 3D head models to predict photon movement and then compared the results to actual light data. The results aligned, adding credibility to what may one day be a revolutionary shift in brain imaging. It's early days. Scanning took 30 minutes, and the conditions were highly specific. But it's a proof of concept with massive potential. For now, it's just one beam of light. In the future, it could be the foundation of a global leap in how doctors see the a Laser Replace MRI Scans? One Bold Experiment Says Yes first appeared on Men's Journal on Jun 22, 2025
Yahoo
2 hours ago
- Yahoo
Mounjaro weight loss jab: All you need to know
GPs in England will be able to prescribe weight loss jabs for the first time on the NHS on Monday, as the health service begins its mass rollout. Some 220,000 people with the 'greatest need' are expected to receive Mounjaro, also known as tirzepatide and made by Lilly, through the NHS over the next three years. Here the PA news agency takes a look at the drug and the rollout. – How does tirzepatide work? Tirzepatide, or Mounjaro, is an antidiabetic drug which lowers blood sugar levels and slows down how quickly food is digested. It makes you feel fuller for longer and therefore less hungry. If the jab is recommended by a healthcare professional, those using it will need to eat a balanced, reduced-calorie diet and to exercise regularly while taking it, according to the NHS website. – Who might be eligible for the drug? In the first year of the programme, the drug will be offered to people with a body mass index (BMI) score of more than 40 who have at least four other health problems linked to obesity, such as type 2 diabetes; high blood pressure; heart disease; and obstructive sleep apnoea. It was previously only accessible to patients through a special weight loss service, to severely obese people who also suffer from a range of other health problems. Estimates suggest around 1.5 million people in the UK are already taking weight loss drugs, which may have been prescribed through specialist weight loss services or via private prescription. – How would it be administered? The drug is usually delivered through a self-administered weekly injection which a doctor or nurse will show patients how to use, the NHS website says. – Who cannot take tirzepatide? Mounjaro is not recommended for those who are pregnant or planning to get pregnant, breastfeeding or have certain health conditions, according to the NHS. For those taking the contraceptive pill and using tirzepatide, the NHS recommends using an additional method of contraception, such as a condom, for the first four weeks of treatment and for four weeks after each dose increase as the contraceptive pill may not be absorbed by the body during this time. – What are the potential side effects? Potential side effects of tirzepatide include nausea, vomiting, diarrhoea and constipation, according to the National Institute for Health and Care Excellence.
Yahoo
2 hours ago
- Yahoo
Mass rollout of weight loss jabs begins on NHS
The mass rollout of weight loss jabs on the NHS in England will begin on Monday as GPs are allowed to prescribe the drugs for the first time. Around 220,000 people with 'greatest need' are expected to receive Mounjaro, also known as tirzepatide and made by Lilly through the NHS over the next three years. The drug is an antidiabetic drug which lowers blood sugar levels and and slows down how quickly food is digested. From Monday, GPs in England will be allowed to prescribe Mounjaro to severely obese people who also suffer from a range of other health problems. Patients previously needed to access the drugs through a special weight loss service. But leading family doctors said some GPs have expressed concern about the additional workload linked to the rollout. And pharmacy experts also said there could be pressure on supplies of the drug. In the first year of the programme, the drug will be offered to people with a body mass index (BMI) score of over 40 who have at least four other health problems linked to obesity, such as type 2 diabetes; high blood pressure; heart disease; and obstructive sleep apnoea. Estimates suggest around 1.5 million people in the UK are already taking weight loss drugs, which may have been prescribed through specialist weight loss services or via private prescription. Dr Claire Fuller, from NHS England, said: 'This is an important next step in the rollout of weight loss drugs, with community-based services now able to offer this treatment from today. 'We urgently need to address rising levels of obesity and prioritise support for those who are experiencing severe ill health – and greater access to weight loss drugs will make a significant difference to the lives of those people. 'These drugs are an important tool alongside the range of wraparound NHS support and advice on good nutrition and increasing physical activity, which will be vital in helping some people lose weight and reduce their risk of serious long-term conditions. 'While not everyone will be eligible for weight loss drugs, it's important that anyone who is worried about the impact of their weight on their health discusses the range of NHS support available with their healthcare professional.' Professor Kamila Hawthorne, chairwoman of the Royal College of GPs, said: 'While we recognise the potential benefits of weight loss drugs, we know many GPs are concerned about the implications of the rollout of weight loss drugs into general practice, both in terms of workload and training to appropriately initiate and manage these treatments. 'The college shares these concerns, which is why we were pleased NHS England suggested a phased roll-out of Mounjaro as a treatment for weight loss. As and when this is escalated, appropriate resourcing for general practice – including access to 'wraparound' services – and training for GPs must follow. GLP-1s like #Ozempic, #Saxenda, #Wegovy, or #Mounjaro are not an easy #weightloss hack. Find out more about:🔵what they are ❓🔵how they're used 💊🔵who they help 💪 🔗Learn more: — EU Medicines Agency (@EMA_News) January 4, 2025 She added: 'GPs and our teams are already working under intense workload and workforce pressures, and this must be factored into this rollout in order to guarantee it can be delivered safely. 'More widely, whilst weight loss medications have a lot of potential benefits for patients who are struggling to lose weight and who meet all the clinical criteria for a prescription, they mustn't be seen as a 'silver bullet' to aid weight loss. 'We also need to see a focus on prevention, stopping people becoming overweight in the first place so they don't require a medical intervention later.' Dr Hawthorne said there is no 'one size fits all approach' and that the rollout of the jabs should not 'come at the expense of other weight loss service'. She continued: 'The roll-out of weight loss medications in the NHS will need to be consistently evaluated to ensure that there is evidence that these prescriptions are of long-term benefit to patients.' Olivier Picard, chairman of the National Pharmacy Association, said: 'The demand for weight loss jabs continues to rise sharply, and more GPs have been directing patients back to pharmacies after initial inquiries, to access these treatments privately. 'As the NHS is now moving to implement National Institute for Health and Care Excellence (Nice) guidance, and tirzepatide becomes prescribable to more patients, we expect to see prescription volumes increase rapidly. 'However, NHS provision won't meet demand straight away, so we fully expect that many people will continue seeking it privately from a pharmacy. 'Pharmacists are experts in medication and many of us have lots of experience delivering weight loss injections as part of a package of care including lifestyle advice. 'We are well placed to help roll out weight loss treatment on the NHS, with the right funding to support it. 'The biggest concern we have is that prescribing these medications alone misses the point. 'They should be part of a comprehensive weight management strategy – combining lifestyle coaching, exercise, and nutritional guidance. In reality, many GPs lack the bandwidth to deliver the level of support needed to ensure proper understanding and follow-up. 'As a result, we could end up in a situation where patients are prescribed the medication, lose weight, and then experience rebound weight gain once the course ends – simply because the foundational lifestyle changes weren't addressed.' Around 29% of the adult population in the UK is obese. Health Secretary Wes Streeting said: 'Obesity is now one of the leading causes of ill health, costing the NHS billions. Yet we now have the science, technology, and knowledge to end the obesity epidemic, if we seize this opportunity. 'Obesity jabs are used by 1.5 million people in the UK, mainly through private prescriptions. The NHS was founded on a promise to 'universalise the best', and this Government is determined to bring revolutionary modern treatments to everyone who needs them, not just those who can afford to pay. 'This rollout is an important step in making these medicines more widely available, and beginning to shift the focus of healthcare from sickness to prevention, which our forthcoming 10-year plan will deliver.'
